LH vs OVID · P/E 23, rev $13.95B vs rev $733.0K
Laboratory Corporation of America Holdings (LH) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
LH currently screens at market cap $21.07B and trailing P/E 22.8. OVID currently screens at market cap $23.5M.
Not investment advice. Open the LH and OVID stock pages for the full models.
Not investment advice.